Ophthalmology and Visual Sciences Career Development K12 Program

眼科和视觉科学职业发展 K12 计划

• 批准号: 9040968
• 负责人: ROBERT N WEINREB
• 金额: $ 43.98万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-04-01 至 2020-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9040968
• 关键词: Appointment; Area; Award; Biomedical Engineering; California; Clinical; Clinical Sciences; Department chair; Education; Educational Curriculum; Ethics; Fellowship; Genomics; Glaucoma; Goals; Grant; Human Subject Research; Individual; K-Series Research Career Programs; Lead; Leadership; Mentored Clinical Scientist Development Program; Mentors; Minority; Ophthalmologist; Ophthalmology; Preparation; Proteomics; Recruitment Activity; Research; Residencies; Scientist; Structure; Telemedicine; Training; United States National Institutes of Health; Universities; Woman; Writing; base; career; career development; clinically relevant; education research; eye center; next generation; programs; responsible research conduct; skills; statistics; stem cell biology; vision science; visual neuroscience

 DESCRIPTION (provided by applicant): The overall objective of the NEI Mentored Clinical Scientist Development Program Award at UCSD is to develop outstanding clinician scientists to successfully compete at the national level for NIH grants and emerge as leaders within academic Ophthalmology. Through this institutional career development award, we will mentor clinician scientists toward independent academic appointments in ophthalmology. Since 1991, the University of California San Diego Shiley Eye Center has excelled in mentoring the career development of academic ophthalmologists in all fields, particularly in the field of glaucoma. Many of these individuals now lead successful research and clinical careers around the world; they include Department Chairs, Division Chiefs and impactful academicians. We will amplify these strengths through a structured program of mentoring, research and education to identify and mentor the next generation of academic clinician scientists, expand our emphasis to career development across all subspecialty areas of ophthalmology. With an emphasis on recruiting strong applications from women and minority applicants, Scholars will be selected each year after their completion of a post-residency clinical fellowship in ophthalmology. The Scholar will undertake these activities in the area of basic and/or clinical sciences appropriate to their scientific focus, and by partnering with active clinician scientist mentors to facilitate career development. Each Scholar will be trained in clinically relevant research, statistics, scientific writing, grant preparation, ethics, leadership and the responsible conduct of research. Additional aspects of the curriculum of each Scholar will be individualized by the Program Director (PI), Research Director, Education Director, Executive Committee, Mentoring Group, and lead mentor, based upon the Scholar's selected primary research track and his/her skills, background and career goals. Each Scholar will create an original research program and through this Award develop an independent academic career. We propose six primary research tracks: (1) Visual Neuroscience, (2) Genomics and Proteomics, (3) Bioengineering, (4) Stem cell biology, (5) Computational Ophthalmology (and Telemedicine), and (6) Clinical (human subjects) Research.

 描述（由应用程序提供）：UCSD的NEI指导临床科学家发展计划奖的总体目标是开发杰出的临床科学家，以成功地在NIH助学金的国家一级竞争，并成为学术眼科中的领导者。通过这一机构职业发展奖，我们将精神临床科学家对眼科独立的学术任命。自1991年以来，加利福尼亚大学圣地亚·谢里眼中心（San Diego Shiley Eye Center）在所有领域，尤其是在青光眼领域的学术眼科医生的职业发展方面都非常出色。这些人中的许多人现在领导着全球成功的研究和临床职业。它们包括部门主席，部门负责人和有影响力的院士。我们将通过一个结构化的心理，研究和教育计划来扩大这些优势，以识别和指导下一代学术临床科学，将紧急情况扩展到眼科所有副学科领域的职业发展。着重于招募妇女和少数民族申请的强大申请，在完成居住后临床奖学金后，将每年选择学者。该学者将在适合其科学重点的基础和/或临床科学领域进行这些活动，并通过与活跃的临床科学家导师合作以促进职业发展。每个学者将接受临床相关的研究，统计，科学写作，赠款准备，道德，领导和负责任的研究的培训。每个学者课程的其他方面将由计划主任（PI），研究总监，教育总监，执行委员会，指导小组和首席导师基于该学者所选的主要研究轨道以及他/她/她/她/她的技能，背景和职业目标。每个学者将创建一个原始的研究计划，并通过该奖项发展独立的学术生涯。我们提出了六个主要研究轨道：（1）视觉神经科学，（2）基因组学和蛋白质组学，（3）生物工程，（4）干细胞生物学，（5）计算眼科（和远程医疗）和（6）临床（人类受试者）研究。